Safely and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia

Authors
Wolfe, ML Vartanian, SF Ross, JL Bansavich, LL Mohler, ER Meagher, E Friedrich, CA Rader, DJ
Citation
Ml. Wolfe et al., Safely and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia, AM J CARD, 87(4), 2001, pp. 476
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
87
Issue
4
Year of publication
2001
Database
ISI
SICI code
0002-9149(20010215)87:4<476:SAEONW>2.0.ZU;2-O
Abstract
Niaspan, when added to a stable dose of a statin in 66 subjects, was found to be safe and highly effective in improving lipid parameters. Subgroup ana lyses demonstrated its effectiveness in lowering low-density lipoprotein ch olesterol in persons not at the National Cholesterol and Education Program low-density lipoprotein cholesterol target and in raising high-density lipo protein cholesterol in persons with levels <40 mg/dl.